UnitedHealth Group will release its Q3 2025 financial results on October 28, 2025, before the market opens. The company will host a teleconference at 8:00 a.m. ET to discuss the results with analysts and investors. The earnings release is expected to cover the company's performance in the health care and well-being sector, with a focus on its two distinct businesses, Optum and UnitedHealthcare.
UnitedHealth Group Incorporated (UNH) will release its third quarter 2025 financial results on October 28, 2025, before the market opens. The company will host a teleconference at 8:00 a.m. ET to discuss the results with analysts and investors. The earnings release is expected to cover the company's performance in the health care and well-being sector, with a focus on its two distinct businesses, Optum and UnitedHealthcare.
The earnings release comes amid a challenging year for UnitedHealth. In July 2025, the company issued its 2025 adjusted EPS guidance, projecting adjusted EPS of at least $16 on revenues of $445.5-$448 billion. However, analysts have been cautious, with two downward revisions to the 2025 and 2026 earnings estimates over the past month, and no upward adjustments
UnitedHealth Reaffirms 2025 EPS Guidance: Time to Buy or Wait?[1].
UnitedHealth has faced regulatory and legal issues, including probes from the Justice Department into its Medicare billing practices and reimbursement policies. The company has also been under scrutiny for its handling of loans to healthcare providers following the 2024 Change Healthcare cyberattack. Additionally, the company is facing rising high-acuity care volumes, worsening Medicare Advantage dynamics, and a climbing medical loss ratio
UnitedHealth Reaffirms 2025 EPS Guidance: Time to Buy or Wait?[1].
Despite these challenges, UnitedHealth maintains a dominant position in the U.S. healthcare sector, supported by scale, diversification, and a vast customer base. The company has been actively engaging with the Trump administration to address government investigations and changes in federal payments, increasing its lobbying expenditure in the first half of 2025
UnitedHealth Boosts Washington Lobbying Budget As Trump Administration Targets Medicare Practices: Report[2].
Investors are encouraged to tune in to the earnings call to gain insights into the company's performance and strategies for navigating the current challenges. The call will be webcast on the Investor Relations page of the company’s website (www.unitedhealthgroup.com), with a replay available through November 11.
Comments
No comments yet